Merge branch 'master' into 10299-genetable-version

docs/News.md

@@ -1,3 +1,19 @@
+## December 18, 2024
+*   **Added data** consisting of 34,904 samples from 9 studies:
+    * [MSK-CHORD (MSK, Nature 2024)](https://www.cbioportal.org/study/summary?id=msk_chord_2024) *25040 samples*
+    * [MSK ctDNA Sequencing Cohort (MSK, Nature Med 2024)](https://www.cbioportal.org/study/summary?id=msk_ctdna_vte_2024) *5567 samples*
+    * [Prostate Cancer (MSK, Clin Cancer Res 2024)](https://www.cbioportal.org/study/summary?id=prostate_msk_2024) *2260 samples*
+	* [Hepatocellular Carcinoma (MSK, Clin Cancer Res 2024)](https://www.cbioportal.org/study/summary?id=hcc_msk_2024) *1370 samples*
+    * [Pancreatic Cancer (MSK, Cancer Cell 2024)](https://www.cbioportal.org/study/summary?id=pancreas_msk_2024) *395 samples*
+    * [Metastatic Pancreatic Neuroendocrine Tumor (MSK, JCO Precis Oncol 2018)](https://www.cbioportal.org/study/summary?id=panet_msk_2018) *96 samples*
+    * [Recurrent CNS Lymphoma - Ibrutinib Long Term Follow Up (MSK, Cancer Cell 2024)](https://www.cbioportal.org/study/summary?id=pcnsl_msk_2024) *86 samples*
+    * [Metastatic Breast Cancer (DFCI, Cancer Discovery 2020)](https://www.cbioportal.org/study/summary?id=brca_dfci_2020) *59 samples*
+    * [Atypical Small Cell Lung Cancer (MSK, Cancer Discovery 2024)](https://www.cbioportal.org/study/summary?id=asclc_msk_2024) *31 samples*
+
+*   **Data Improvement**
+
+    * TBL scores addition: Tumor Break Load (TBL) scores is added to PCAWG, CCLE, and all 32 TCGA Pan-Cancer studies. The data is sourced from [Lakbir et al., NPJ Precision Oncolgy 2024](https://www.biorxiv.org/content/10.1101/2024.12.08.626771v1.full) and [Lakbir et al., Eur J Cancer 2022](https://pubmed.ncbi.nlm.nih.gov/36334560/)
+
 ## December 11, 2024
 *   **Added data** consisting of 5,567 samples from 6 TARGET studies from the [Genomic Data Commons (GDC)](https://gdc.cancer.gov) as part of the [Cancer Research Data Commons (NCI-CRDC)](https://datacommons.cancer.gov) initiative.
     * [Acute Myeloid Leukemia (TARGET, GDC)](https://www.cbioportal.org/study/summary?id=aml_target_gdc) *2482 samples*

docs/deployment/customization/application.properties-Reference.md

@@ -50,6 +50,14 @@ skin.show_about_tab=
 
 **Note:** `skin.show_tools_tab` refers to the `Visualize Your Data` tab, while `skin.show_data_tab` refers to the `Data Sets` tab.
 
+### Show donate button
+
+We kindly ask for your support by enabling the “Donate” button on your portals to help fund our mission. The button will direct users to https://docs.cbioportal.org/donate/, where they can learn more about how the funding is utilized. You can activate it through:
+
+```
+skin.show_donate_button=true
+```
+
 ### Cross Cancer Study Query Default
 
 The cross cancer study query default is a list of studies used when querying one or more genes and not specifying a specific study or list of studies. There are two ways in which the default cross cancer study list is used:

src/main/resources/application.properties.EXAMPLE

@@ -69,6 +69,9 @@ skin.show_tutorials_tab=true
 skin.show_faqs_tab=true
 skin.show_tools_tab=true
 skin.show_about_tab=true
+# We kindly ask for your support by enabling the "Donate" button
+# https://cbioportal.org/donate
+# skin.show_donate_button=true
 
 # settings controlling the whats new blurb
 skin.right_nav.whats_new_blurb=<p> &bull;<a href="news.jsp"> <b>New data and features released</b></a><br/> &bull;<a href="tools.jsp"> <b>New tools released</b></a> </p> <form action="https://groups.google.com/group/cbioportal-news/boxsubscribe"> &nbsp;&nbsp;&nbsp;&nbsp;<b>Sign up for low-volume email news alerts:</b></br> &nbsp;&nbsp;&nbsp;&nbsp;<input type="text" name="email"> <input type="submit" name="sub" value="Subscribe"> </form> &nbsp;&nbsp;&nbsp;&nbsp;<b>Or follow us <a href="http://www.twitter.com/cbioportal"><i>@cbioportal</i></a> on Twitter</b>